CIK 0001275187 · Accelerated filer
ANGIODYNAMICS INC
Sign in to watch- Ticker
- ANGO
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- May 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 113146460
- Phone
- 5187981215
- Business address
- 14 PLAZA DRIVE, LATHAM, NY, 12110
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $310,688
- in 1 filing
Net −$310,688. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-04-20 | DONNELLY HOWARD W Director | Option exercise · Non-Qualified Stock Option (right to buy) | −6,022 | 0 | ||
| 2022-04-12 | JOHNSON WESLEY Director | Sale | −1,299 | $23.26 | $30K | 79,704 |
| 2022-04-11 | JOHNSON WESLEY Director | Sale | −6,201 | $23.00 | $143K | 80,003 |
| 2022-02-03 | Trowbridge Stephen A EVP and CFO | Shares withheld for taxes | −583 | $20.48 | $12K | 75,498 |
| 2022-02-01 | ROSENZWEIG RICHARD C SVP and General Counsel | Shares withheld for taxes | −1,194 | $21.31 | $25K | 12,904 |
| 2022-01-12 | Trowbridge Stephen A EVP and CFO | Purchase | +1,000 | $22.64 | $23K | 76,081 |
| 2022-01-11 | Clemmer James C President and CEO | Purchase | +10,000 | $22.84 | $228K | 390,764 |
| 2021-10-31 | Centea Scott Sr. VP/GM, Global VIT | Shares withheld for taxes | −953 | $29.37 | $28K | 45,291 |
| 2021-10-20 | Helsel Dave SVP Global Operations and R&D | Sale | −3,494 | $27.97 | $98K | 26,387 |
| 2021-10-15 | Centea Scott Sr. VP/GM, Global VIT | Option exercise | +12,000 | $16.77 | $201K | 58,244 |
| 2021-10-15 | Centea Scott Sr. VP/GM, Global VIT | Sale | −12,000 | $27.92 | $335K | 46,244 |
| 2021-10-15 | Centea Scott Sr. VP/GM, Global VIT | Option exercise · Non-Qualified Stock Option (right to buy) | −12,000 | 0 | ||
| 2021-10-05 | Campbell Chad Thomas SVP/GM, Vascular Access | Option exercise | +10,748 | $16.59 | $178K | 42,489 |
| 2021-10-05 | Campbell Chad Thomas SVP/GM, Vascular Access | Sale | −10,748 | $27.15 | $292K | 31,741 |
| 2021-10-05 | Campbell Chad Thomas SVP/GM, Vascular Access | Option exercise · Non-Qualified Stock Option (right to buy) | −10,748 | 0 | ||
| 2021-08-12 | Campbell Chad Thomas SVP/GM, Vascular Access | Option exercise | +8,210 | 34,871 | ||
| 2021-08-12 | Campbell Chad Thomas SVP/GM, Vascular Access | Shares withheld for taxes | −3,130 | $27.29 | $85K | 31,741 |
| 2021-08-12 | Campbell Chad Thomas SVP/GM, Vascular Access | Option exercise · Performance Right | −7,079 | 0 | ||
| 2021-08-12 | Clemmer James C President and CEO | Option exercise | +40,528 | 399,695 | ||
| 2021-08-12 | Clemmer James C President and CEO | Shares withheld for taxes | −21,532 | $27.29 | $588K | 378,163 |
Page 16 of 30 · 589 trades